Slowing of Peripheral Artery Disease: Another Liraglutide Benefit? | MedPage Today

Diabetes

Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave